|
1
|
Yu X, Zhang W, Ning Q and Luo X:
MicroRNA-34a inhibits human brain glioma cell growth by
down-regulation of Notch1. J Huazhong Univ Sci Technolog Med Sci.
32:370–374. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Van Meir EG, Hadjipanayis CG, Norden AD,
Shu HK, Wen PY and Olson JJ: Exciting new advances in
neuro-oncology: The avenue to a cure for malignant glioma. CA
Cancer J Clin. 60:166–193. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Hou SX, Ding BJ, Li HZ, Wang L, Xia F, Du
F, Liu LJ, Liu YH, Liu XD, Jia JF, et al: Identification of
microRNA-205 as a potential prognostic indicator for human glioma.
J Clin Neurosci. 20:933–937. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Wang R, Jiao Z, Li R, et al: p68 RNA
helicase promotes glioma cell proliferation in vitro and in vivo
via direct regulation of NF-κB transcription factor p50. Neuro
Oncol. 14:1116–1124. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Feng SY, Dong CG, Wu WK, et al: Lentiviral
expression of anti-microRNAs tar geting miR-27a inhibits
proliferation and invasiveness of U87 gliomacells. Mol Med Rep.
6:275–281. 2012.PubMed/NCBI
|
|
6
|
Chan JA, Krichevsky AM and Kosik KS:
MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells.
Cancer Res. 65:6029–6033. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Bartel DP: MicroRNAs: Target recognition
and regulatory functions. Cell. 136:215–233. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Long JM and Lahiri DK: Advances in
microRNA experimental approaches to study physiological regulation
of gene products implicated in CNS disorders. Exp Neurol.
235:402–418. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Park S and James CD: ECop
(EGFR-coamplified and overexpressed protein), a novel protein,
regulates NF-kappaB transcriptional activity and associated
apoptotic response in an IkappaBalpha-dependent manner. Oncogene.
24:2495–2502. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Xu B, Hsu PK, Karayiorgou M and Gogos JA:
MicroRNA dysregulation in neuropsychiatric disorders and cognitive
dysfunction. Neurobiol Dis. 46:291–301. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Godlewski J, Nowicki MO, Bronisz A,
Williams S, Otsuki A, Nuovo G, Raychaudhury A, Newton HB, Chiocca
EA and Lawler S: Targeting of the Bmi-1 oncogene/stem cell renewal
factor by microRNA-128 inhibits glioma proliferation and
self-renewal. Cancer Res. 68:9125–9130. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Silber J, Lim DA, Petritsch C, Persson AI,
Maunakea AK, Yu M, Vandenberg SR, Ginzinger DG, James CD, Costello
JF, et al: miR-124 and miR-137 inhibit proliferation of
glioblastoma multiforme cells and induce differentiation of brain
tumor stem cells. BMC Med. 6:142008. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Rao SAM, Santosh V and Somasundaram K:
Genome-wide expression profiling identifies deregulated miRNAs in
malignant astrocytoma. Mod Pathol. 23:1404–1417. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Song L, Huang Q, Chen K, Liu L, Lin C, Dai
T, Yu C, Wu Z and Li J: miR-218 inhibits the invasive ability of
glioma cells by direct downregulation of IKK-β. Biochem Biophys Res
Commun. 402:135–140. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Xia H, Yan Y, Hu M, et al: MiR-218
sensitizes glioma cells to apoptosis and inhibits tumorigenicity by
regulating ECOP-mediated suppression of NF-κB activity. Neuro
Oncol. 15:413–422. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Liu Y, Yan W, Zhang W, et al: MiR-218
reverses high invasiveness of glioblastoma cells by targeting the
oncogenic transcription factor LEF1. Oncol Rep. 28:1013–1021.
2012.PubMed/NCBI
|
|
17
|
Zhang JM, Sun CY, Yu SZ, et al:
Relationship between miR-218 and CDK6 expression and their
biological impact on glioma cell proliferation and apoptosis.
Zhonghua Bing Li Xue Za Zhi. 40:454–459. 2011.[(In Chinese)].
PubMed/NCBI
|
|
18
|
Louis DN, Ohgaki H, Wiestler OD, et al:
The 2007 WHO classification of tumours of the central nervous
system. Acta Neuropathol. 114:97–109. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Cai J, Wu J, Zhang H, Fang L, Huang Y,
Yang Y, Zhu X, Li R and Li M: miR-186 downregulation correlates
with poor survival in lung adenocarcinoma, where it interferes with
cell-cycle regulation. Cancer Res. 73:756–766. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Molinari M: Cell cycle checkpoints and
their inactivation in human cancer. Cell Prolif. 33:261–274. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Sherr CJ and Roberts JM: CDK inhibitors:
Positive and negative regulators of G1-phase progression. Genes
Dev. 13:1501–1512. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wu Z, He B, He J and Mao X: Upregulation
of miR-153 promotes cell proliferation via downregulation of the
PTEN tumor suppressor gene in human prostate cancer. Prostate.
73:596–604. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Jovanovic M and Hengartner MO: miRNAs and
apoptosis: RNAs to die for. Oncogene. 25:6176–6187. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Xiao B, Tan L, He B, et al: MiRNA-329
targeting E2F1 inhibits cell proliferation in glioma cells. J
Transl Med. 11:1722013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Kent OA and Mendell JT: A small piece in
the cancer puzzle: microRNAs as tumor suppressors and oncogenes.
Oncogene. 25:6188–6196. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Martinez I, Gardiner AS, Board KF, Monzon
FA, Edwards RP and Khan SA: Human papillomavirus type 16 reduces
the expression of microRNA-218 in cervical carcinoma cells.
Oncogene. 27:2575–2582. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Petrocca F, Visone R, Onelli MR, Shah MH,
Nicoloso MS, de Martino I, Iliopoulos D, Pilozzi E, Liu CG, Negrini
M, et al: E2F1-regulated microRNAs impair TGFbeta-dependent
cell-cycle arrest and apoptosis in gastric cancer. Cancer Cell.
13:272–286. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Yanaihara N, Caplen N, Bowman E, Seike M,
Kumamoto K, Yi M, Stephens RM, Okamoto A, Yokota J, Tanaka T, et
al: Unique microRNA molecular profiles in lung cancer diagnosis and
prognosis. Cancer Cell. 9:189–198. 2006. View Article : Google Scholar : PubMed/NCBI
|
